Article Versions Notes

Ma X, Hu Q, Jiang T, Chen Y, Zhang W, Gao P, Zeng J, Efferth T. Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism. Molecules. 2024; 29(17):4031. https://doi.org/10.3390/molecules29174031

Ma, Xiao, Qichao Hu, Tao Jiang, Yuan Chen, Wenwen Zhang, Pan Gao, Jinhao Zeng, and Thomas Efferth. 2024. "Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism" Molecules 29, no. 17: 4031. https://doi.org/10.3390/molecules29174031

Ma, X., Hu, Q., Jiang, T., Chen, Y., Zhang, W., Gao, P., Zeng, J., & Efferth, T. (2024). Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism. Molecules, 29(17), 4031. https://doi.org/10.3390/molecules29174031